Ignite Creation Date:
2024-05-06 @ 5:54 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05471271
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2022-06-29
Brief Title:
IL-2 PET Imaging in Advanced Solid Tumours
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Study Overview
Official Title:
An Open Label Pilot Study of 18AlF-RESCA-IL2 Interleukin-2 PET Tracer for Positron Emission Tomography Imaging in Patients Treated With Immune Checkpoint Inhibitors
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an investigator-initiated single-center open-label clinical trial designed to evaluate the safety and PK of the PET tracer 18FAlF-RESCA-IL2 in patients prior to and during treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None